Entrepreneurship for Cardiovascular Health Opportunities (ECHO) is a 12-month national training program supporting cardiovascular research commercialization through education, mentorship, networking, and funding. Led by a diverse team of experts, ECHO fosters...
Entrepreneurship for Cardiovascular Health Opportunities (ECHO) is a 12-month national training program supporting cardiovascular research commercialization through education, mentorship, networking, and funding. Led by a diverse team of experts, ECHO fosters...
Entrepreneurship for Cardiovascular Health Opportunities (ECHO) is a 12-month national training program supporting cardiovascular research commercialization through education, mentorship, networking, and funding. Led by a diverse team of experts, ECHO fosters...
The tools we use in research should reflect the full spectrum of genetic diversity, but they often do not. This is a gap that an international team of scientists is exploring through the lens of induced pluripotent stem cell (iPSC) lines. iPSCs are a type...
Receiving a heart transplant is a life-changing journey, and you may be wondering about your treatment options. This is why The Heart Hub is excited to introduce A Hearts Journey: A Patient & Caregiver Guide to Heart Transplant. This brand-new, interactive...
On March 5, 2025, The Hospital for Sick Children (SickKids) received a significant breakthrough in pediatric research with an $11.7 million award from Genome Canada. As part of the Canadian Precision Health Initiative, a total of $81 million in...
All are welcome to join an ECHO webinar on Tuesday June 21, 2022 (11 am – 12 pm EST) featuring Dr. Harry Rowland (CEO and Co-founder, Endotronix).
Dr. Rowland’s presentation entitled, “Insights from the Endotronix Journey: A PMA Medtech “Startup” Story”, will feature an overview of Endotronix, its technologies and the story behind its success. Endotronix is a medical technology company, delivering an integrated platform that provides comprehensive, reimbursable health management innovations for patients suffering from advanced heart failure. Please see attachment for more details.
Register in advance for this webinar: https://us02web.zoom.us/meeting/register/tZwkc-GrqD0sGtcnluN7KLI2wNtAxZ1kYIx9
ECHO is an entrepreneurship training program, funded and organized in a partnership between (i) the Translational Biology and Engineering Program (TBEP), the University of Toronto component of the Ted Rogers Centre for Heart Research, and (ii) the Health Innovation Hub (H2i).